While the present study indicates that GC-C blunts the severity of mucosal inflammation in the IL-10−/− murine IBD model, we have previously shown that GC-C−/− mice are resistant to DSS-induced epithelial ulceration and colonic injury [16]. Here, GUCY2C is linked to inflammatory bowel disease.